Tudor Investment Corporation »

Moonlake Immunot shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.8M 30k 60.39
2023-09-30 $974k 17k 57.00
2023-06-30 $691k 14k 51.00

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Splunk Inc - US Equity
Pioneer Natural Resources Co - US Equity (PXD)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Spdr Dow Jones Industrial Average Etf Trust - US E ETF Option Call Option (DIA)
Exxon Mobil Corp - US Equity (XOM)
Meta Platforms Inc - US Equity (META)
Bristol-Myers Squibb Co - US Equity (BMY)
Texas Instruments Inc - US Equity Option Call Option (TXN)
Enphase Energy Inc - US Equity Option Call Option (ENPH)
United Parcel Service Inc - US Class B Equity Option Call Option (UPS)
Nvidia Corp - US Equity (NVDA)
Bank Of America Corp - US Equity (BAC)
Estee Lauder Cos Inc/The - US Equity (EL)

View all positions for Tudor Investment Corporation

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
venBio Select Advisor
T. Rowe Price Associates
Citadel Advisors
Federated Investors
Darwin Global Management
Holocene Advisors
Alliancebernstein
Fred Alger Management
Westfield Capital Management Company
Balyasny Asset Management
TimesSquare Capital Management
Caption Management
5AM Venture Management

View all funds holding Moonlake Immunot